The stereotactic surgery devices market size has grown strongly in recent years. It will grow from $22.44 billion in 2025 to $23.84 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of neurological disorders, expansion of neurosurgical centers, increased use of gamma knife systems, adoption of minimally invasive brain procedures, advancements in medical imaging technologies.
The stereotactic surgery devices market size is expected to see strong growth in the next few years. It will grow to $30.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for precision neurosurgery, rising investments in advanced radiosurgery platforms, expansion of AI-assisted surgical planning, growing adoption of non-invasive treatment methods, increasing focus on patient-specific therapy. Major trends in the forecast period include increasing adoption of image-guided stereotactic systems, rising use of robotic-assisted neurosurgical platforms, growing integration of high-precision navigation technologies, expansion of non-invasive radiosurgery solutions, enhanced focus on treatment accuracy and safety.
The rising prevalence of Parkinson's disease and epilepsy is expected to drive the growth of the stereotactic surgical device market in the coming years. Parkinson's disease is a neurodegenerative disorder that leads to involuntary tremors, slow movements, and stiff muscles, while epilepsy is a neurological condition that increases the likelihood of recurring, unprovoked seizures. Stereotactic surgical devices are employed in treating movement disorders, epilepsy, pain, psychiatric conditions, and Parkinson's disease. For example, in November 2024, the British Psychological Society, a UK-based professional body for psychology, reported that in Wales, around 100,000 people live with long-term neurological conditions, including over 41,000 affected by disorders such as Parkinson’s disease, epilepsy, multiple sclerosis, muscular dystrophy, motor neurone disease, and cerebral palsy, with approximately 2,500 new cases of Parkinson’s disease, epilepsy, multiple sclerosis, or motor neurone disease diagnosed annually. Thus, the increasing incidence of Parkinson's disease and epilepsy is fueling growth in the stereotactic surgical device market.
The expanding geriatric population is also expected to support the growth of the stereotactic surgical device market. The geriatric population comprises elderly individuals, generally defined as those aged 65 and above. Stereotactic surgical devices provide minimally invasive and precise treatment solutions for this demographic, addressing the unique health challenges associated with aging. For example, in October 2025, the World Health Organization (WHO), a Switzerland-based UN agency, projected that by 2030, one in six people globally will be aged 60 or older, with this population expected to double to 2.1 billion by 2050. Therefore, the growing geriatric population is contributing to the expansion of the stereotactic surgical device market.
Major companies in the stereotactic surgical device market are focusing on developing innovative technologies to enhance their market position. For example, in May 2023, Brainlab, a medical technology company based in Germany, introduced a new product named ExacTrac Dynamic Surface. This innovation constitutes a surface-guided radiation therapy (SGRT) patient tracking and positioning system. The system integrates high-speed thermal surface tracking technology with an updated ExacTrac X-ray monitoring feature, providing increased versatility and accuracy in patient positioning and monitoring for various treatments, including cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system utilizes a structured blue light pattern on the patient's surface, captured by two 3D cameras, with each surface point augmented by a thermal signature registered by a third in-unit camera.
Major companies operating in the stereotactic surgery devices market are Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, Ion Beam Applications S.A., ZAP Surgical Systems Inc., Brainlab AG, Monteris Medical Holding AG, Renishaw plc, Medtronic plc, Nexstim Plc, FHC Inc., Alpha Omega Engineering Inc., Mitsubishi Heavy Industries Ltd., Inomed Medizintechnik GmbH, MRI Interventions Inc., Modus Medical Devices Inc., Scopis GmbH, Neuropace Inc., Adeor Medical AG, Huiheng Group Co Ltd.
North America was the largest region in the stereotactic surgery devices market in 2025. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stereotactic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the stereotactic surgery devices market by increasing costs of imported imaging modules, radiation delivery systems, robotic components, and precision control software. Hospitals and specialty neurosurgical centers in North America and Europe are most affected due to reliance on high-end imported systems, while Asia-Pacific faces higher capital costs for technology acquisition. These tariffs are increasing system prices and slowing installation timelines. However, they are also encouraging localized assembly, regional service partnerships, and domestic innovation in stereotactic surgical technologies.
The stereotactic surgery devices market research report is one of a series of new reports that provides stereotactic surgery devices market statistics, including stereotactic surgery devices industry global market size, regional shares, competitors with a stereotactic surgery devices market share, detailed stereotactic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the stereotactic surgery devices industry. This stereotactic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A stereotactic surgical device is a technology utilized to precisely locate specific brain regions by employing a set of three coordinates, all while maintaining the head in a fixed position. This technology plays a crucial role in stereotactic surgery, facilitating the implantation of substances such as medications or hormones into the brain.
The market research report on stereotactic surgical devices is part of a comprehensive series of reports by The Business Research Company. This report offers statistical insights into the stereotactic surgical devices market, encompassing global market size, regional distribution, competitors and their market shares, detailed market segments within the stereotactic surgical devices industry, prevalent market trends, opportunities, and any additional data essential for success in the stereotactic surgical devices sector. Providing a thorough perspective, the research report conducts an in-depth analysis of both current and future scenarios within the industry.
The stereotactic surgical device market consists of sales of intracranial drilling, intracranial injections, and brain cannulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The stereotactic surgery devices market size is expected to see strong growth in the next few years. It will grow to $30.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for precision neurosurgery, rising investments in advanced radiosurgery platforms, expansion of AI-assisted surgical planning, growing adoption of non-invasive treatment methods, increasing focus on patient-specific therapy. Major trends in the forecast period include increasing adoption of image-guided stereotactic systems, rising use of robotic-assisted neurosurgical platforms, growing integration of high-precision navigation technologies, expansion of non-invasive radiosurgery solutions, enhanced focus on treatment accuracy and safety.
The rising prevalence of Parkinson's disease and epilepsy is expected to drive the growth of the stereotactic surgical device market in the coming years. Parkinson's disease is a neurodegenerative disorder that leads to involuntary tremors, slow movements, and stiff muscles, while epilepsy is a neurological condition that increases the likelihood of recurring, unprovoked seizures. Stereotactic surgical devices are employed in treating movement disorders, epilepsy, pain, psychiatric conditions, and Parkinson's disease. For example, in November 2024, the British Psychological Society, a UK-based professional body for psychology, reported that in Wales, around 100,000 people live with long-term neurological conditions, including over 41,000 affected by disorders such as Parkinson’s disease, epilepsy, multiple sclerosis, muscular dystrophy, motor neurone disease, and cerebral palsy, with approximately 2,500 new cases of Parkinson’s disease, epilepsy, multiple sclerosis, or motor neurone disease diagnosed annually. Thus, the increasing incidence of Parkinson's disease and epilepsy is fueling growth in the stereotactic surgical device market.
The expanding geriatric population is also expected to support the growth of the stereotactic surgical device market. The geriatric population comprises elderly individuals, generally defined as those aged 65 and above. Stereotactic surgical devices provide minimally invasive and precise treatment solutions for this demographic, addressing the unique health challenges associated with aging. For example, in October 2025, the World Health Organization (WHO), a Switzerland-based UN agency, projected that by 2030, one in six people globally will be aged 60 or older, with this population expected to double to 2.1 billion by 2050. Therefore, the growing geriatric population is contributing to the expansion of the stereotactic surgical device market.
Major companies in the stereotactic surgical device market are focusing on developing innovative technologies to enhance their market position. For example, in May 2023, Brainlab, a medical technology company based in Germany, introduced a new product named ExacTrac Dynamic Surface. This innovation constitutes a surface-guided radiation therapy (SGRT) patient tracking and positioning system. The system integrates high-speed thermal surface tracking technology with an updated ExacTrac X-ray monitoring feature, providing increased versatility and accuracy in patient positioning and monitoring for various treatments, including cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system utilizes a structured blue light pattern on the patient's surface, captured by two 3D cameras, with each surface point augmented by a thermal signature registered by a third in-unit camera.
Major companies operating in the stereotactic surgery devices market are Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, Ion Beam Applications S.A., ZAP Surgical Systems Inc., Brainlab AG, Monteris Medical Holding AG, Renishaw plc, Medtronic plc, Nexstim Plc, FHC Inc., Alpha Omega Engineering Inc., Mitsubishi Heavy Industries Ltd., Inomed Medizintechnik GmbH, MRI Interventions Inc., Modus Medical Devices Inc., Scopis GmbH, Neuropace Inc., Adeor Medical AG, Huiheng Group Co Ltd.
North America was the largest region in the stereotactic surgery devices market in 2025. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stereotactic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the stereotactic surgery devices market by increasing costs of imported imaging modules, radiation delivery systems, robotic components, and precision control software. Hospitals and specialty neurosurgical centers in North America and Europe are most affected due to reliance on high-end imported systems, while Asia-Pacific faces higher capital costs for technology acquisition. These tariffs are increasing system prices and slowing installation timelines. However, they are also encouraging localized assembly, regional service partnerships, and domestic innovation in stereotactic surgical technologies.
The stereotactic surgery devices market research report is one of a series of new reports that provides stereotactic surgery devices market statistics, including stereotactic surgery devices industry global market size, regional shares, competitors with a stereotactic surgery devices market share, detailed stereotactic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the stereotactic surgery devices industry. This stereotactic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A stereotactic surgical device is a technology utilized to precisely locate specific brain regions by employing a set of three coordinates, all while maintaining the head in a fixed position. This technology plays a crucial role in stereotactic surgery, facilitating the implantation of substances such as medications or hormones into the brain.
The market research report on stereotactic surgical devices is part of a comprehensive series of reports by The Business Research Company. This report offers statistical insights into the stereotactic surgical devices market, encompassing global market size, regional distribution, competitors and their market shares, detailed market segments within the stereotactic surgical devices industry, prevalent market trends, opportunities, and any additional data essential for success in the stereotactic surgical devices sector. Providing a thorough perspective, the research report conducts an in-depth analysis of both current and future scenarios within the industry.
The stereotactic surgical device market consists of sales of intracranial drilling, intracranial injections, and brain cannulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Stereotactic Surgery Devices Market Characteristics
3. Stereotactic Surgery Devices Market Supply Chain Analysis
4. Global Stereotactic Surgery Devices Market Trends and Strategies
5. Stereotactic Surgery Devices Market Analysis of End Use Industries
7. Global Stereotactic Surgery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Stereotactic Surgery Devices Total Addressable Market (TAM) Analysis for the Market
9. Stereotactic Surgery Devices Market Segmentation
10. Stereotactic Surgery Devices Market Regional and Country Analysis
11. Asia-Pacific Stereotactic Surgery Devices Market
12. China Stereotactic Surgery Devices Market
13. India Stereotactic Surgery Devices Market
14. Japan Stereotactic Surgery Devices Market
15. Australia Stereotactic Surgery Devices Market
16. Indonesia Stereotactic Surgery Devices Market
17. South Korea Stereotactic Surgery Devices Market
18. Taiwan Stereotactic Surgery Devices Market
19. South East Asia Stereotactic Surgery Devices Market
20. Western Europe Stereotactic Surgery Devices Market
21. UK Stereotactic Surgery Devices Market
22. Germany Stereotactic Surgery Devices Market
23. France Stereotactic Surgery Devices Market
24. Italy Stereotactic Surgery Devices Market
25. Spain Stereotactic Surgery Devices Market
26. Eastern Europe Stereotactic Surgery Devices Market
27. Russia Stereotactic Surgery Devices Market
28. North America Stereotactic Surgery Devices Market
29. USA Stereotactic Surgery Devices Market
30. Canada Stereotactic Surgery Devices Market
31. South America Stereotactic Surgery Devices Market
32. Brazil Stereotactic Surgery Devices Market
33. Middle East Stereotactic Surgery Devices Market
34. Africa Stereotactic Surgery Devices Market
36. Stereotactic Surgery Devices Market Competitive Landscape and Company Profiles
37. Stereotactic Surgery Devices Market Other Major and Innovative Companies
40. Stereotactic Surgery Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Stereotactic Surgery Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses stereotactic surgery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for stereotactic surgery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stereotactic surgery devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Gamma Knife; Line Accelerator (LINAC) Machines; CyberKnife2) By Application: Brain Tumor Treatment; Arteriovenous Malformations Treatment; Parkinsons Disease; Epilepsy; Other Applications
3) By End User: Hospitals; Specialty Neurosurgical Centers; Cancer Treatment Centers; Academic And Research Medical Centers
Subsegments:
1) By Gamma Knife: Leksell Gamma Knife Perfexion; Leksell Gamma Knife Icon2) By Line Accelerator (LINAC) Machines: Conventional LINAC; Image-Guided Radiation Therapy (IGRT) LINAC
3) By CyberKnife: CyberKnife M6 System; CyberKnife VSI System
Companies Mentioned: Elekta AB; Varian Medical Systems Inc.; Accuray Incorporated; Ion Beam Applications S.A.; ZAP Surgical Systems Inc.; Brainlab AG; Monteris Medical Holding AG; Renishaw plc; Medtronic plc; Nexstim Plc; FHC Inc.; Alpha Omega Engineering Inc.; Mitsubishi Heavy Industries Ltd.; Inomed Medizintechnik GmbH; MRI Interventions Inc.; Modus Medical Devices Inc.; Scopis GmbH; Neuropace Inc.; Adeor Medical AG; Huiheng Group Co Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Stereotactic Surgery Devices market report include:- Elekta AB
- Varian Medical Systems Inc.
- Accuray Incorporated
- Ion Beam Applications S.A.
- ZAP Surgical Systems Inc.
- Brainlab AG
- Monteris Medical Holding AG
- Renishaw plc
- Medtronic plc
- Nexstim Plc
- FHC Inc.
- Alpha Omega Engineering Inc.
- Mitsubishi Heavy Industries Ltd.
- Inomed Medizintechnik GmbH
- MRI Interventions Inc.
- Modus Medical Devices Inc.
- Scopis GmbH
- Neuropace Inc.
- Adeor Medical AG
- Huiheng Group Co Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 23.84 Billion |
| Forecasted Market Value ( USD | $ 30.94 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
